IN VIVO IMMUNOLOGICAL EFFECTS OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) THERAPY IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS

被引：0
|
作者：
Chatzileontiadou, S. [1 ]
Rovati, B. [1 ]
Mariucci, S. [1 ]
Loupakis, F. [2 ,3 ]
Bencardino, K. [4 ]
Manzoni, M. [1 ]
Delfanti, S. [1 ]
Valentino, F. [1 ]
Ricci, V [4 ]
Brugnatelli, S. [1 ]
Ronzoni, M. [4 ]
Falcone, A. [2 ,3 ]
Danova, M. [1 ]
机构：
[1] Fdn IRCCS S Matteo, SC Oncol Med, Pavia, Italy
[2] Azienda USL 6 LIVORNO, Milan, Italy
[3] Univ Pisa, Milan, Italy
[4] HSR San Raffaele, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC)
    Xiong, Feng
    Zhou, Yu-Wen
    Hao, Ya-Ting
    Wei, Gui-Xia
    Chen, Xiao-Rong
    Qiu, Meng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (4-5) : 185 - 192
  • [2] EPHA2 receptor is involved in in vivo acquired resistance to anti-Epidermal Growth Factor Receptor (EGFR) treatment in metastatic colorectal cancer (mCRC)
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Matrone, N.
    Sforza, V.
    Franco, R.
    Morgillo, F.
    Ciardiello, D.
    Giunta, E.
    De Falco, V.
    Zanaletti, N.
    Vitale, P.
    Martinelli, E.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Beyond KRAS: The quest for novel genetic markers predictive for response to anti-epidermal growth factor receptor (EGFR) therapy in patients with metastatic colorectal cancer (mCRC)
    Sood, A.
    McClain, D.
    Seetharam, R.
    Al-rahamneh, M.
    Kaubisch, A.
    Rajdev, L.
    Tanaka, K.
    Mariadason, J.
    Goel, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
    Martinelli, E.
    Ciardiello, D.
    Martini, G.
    Troiani, T.
    Cardone, C.
    Vitiello, P. P.
    Normanno, N.
    Rachiglio, A. M.
    Maiello, E.
    Latiano, T.
    De Vita, F.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2020, 31 (01) : 30 - 40
  • [5] EPHA2 blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Desiderio, V.
    Sforza, V.
    Ferrara, M. L.
    Papaccio, G.
    Mele, L.
    Liguori, G.
    Botti, G.
    Franco, R.
    Morgillo, F.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Treatment patterns and outcomes of acneiform eruptions from anti-epidermal growth factor receptor (EGFR) therapies for metastatic colorectal cancer (MCRC)
    Dascalu, Bogdan
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Treatment patterns and outcomes of acneiform skin eruptions from anti-epidermal growth factor receptor (EGFR) therapies for metastatic colorectal cancer (mCRC)
    Dascalu, Bogdan
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
    Tubb, E. E.
    Nugent, M.
    Spielberger, J.
    Axelrod, R. A.
    Mitchell, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
    Kendall, Anne
    Lord, Rosemary
    Maisey, Nick
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (02) : 142 - 151
  • [10] EPHA2 receptor is involved in in vivo acquired resistance to anti-epidermal growth factor receptor (EGFR) treatment in metastatic colorectal cancer
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Matrone, N.
    Sforza, V.
    Savastano, B.
    Renato, F.
    Morgillo, F.
    Della Corte, C. M.
    Ciardiello, D.
    Giunta, E. F.
    De Falco, V.
    Zanaletti, N.
    Vitale, P.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2017, 28
12345